Last reviewed · How we verify

NCT03397212

Treatment of Withdrawal Symptoms With NADA Acupuncture in Chronic Pain Patients

Status unknown Phase 4 Last updated 11 January 2018
What this trial tests

Phase 4 trial testing NADA acupuncture in Chronic Pain in 50 participants. Status unknown.

Timeline
15 January 2018
Primary endpoint
15 January 2022
15 January 2024

Quick facts

Lead sponsorRigshospitalet, Denmark
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposetreatment
Enrollment50
Start date15 January 2018
Primary completion15 January 2022
Estimated completion15 January 2024
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Rigshospitalet, Denmark

Who can join

18 and older, any sex, with Chronic Pain or Opiate Withdrawal Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project aims at examining the following hypotheses: * Treatment with NADA and clonidine reduces intensity of withdrawal symptoms to a greater extent than treatment with clonidine. * Opioid withdrawal improves pain, physical and mental functioning and reduces opioid consumption 3 months and 1 year after withdrawal.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03397212.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing